| Speakers | Dr. Vernon K. Sondak – H. Lee Moffitt Cancer Center and Research Institute, USA |
| Series |
Topical Talks |
| Relevant extract | Overview of new treatments approved for advanced melanoma in the past few years - Pegylated interferon alfa-2b - Ipilimumab - Mechanism of action - Impact on progression-free and overall survival -... more |
| Speakers | Prof. Ricardo Gazzinelli – University of Massachusetts Medical School, USA |
| Series |
Macrophage Heterogeneity and Function |
| Relevant extract | Malaria and Plasmodium parasites - Innate immune receptors - Plasmodium recognition by host innate immune receptors, and in particular by Toll-like Receptors (TLRs) - Excessive activation of TLRs a... more |
| Speakers | Dr. Henrik Zetterberg – Gothenberg University, Sweden |
| Series |
Drug Discovery and Development in the Neurosciences Biomarkers |
| Relevant extract | Biomarkers for Alzheimer's disease - What is Alzheimer's disease? - -The neuropathology of the disease -Biomarkers reflecting neuropathology - What is CSF? - Different uses of biomarkers - Clinical... more |
| Speakers | Prof. Charles G. Irvin – University of Vermont, USA |
| Series |
Advances in Asthma |
| Relevant extract | Physiology of asthma, a syndrome defined by lung dysfunction - Airflow limitation - Small airways - Reversibility of airflow limitation - Periodicity and variability of airflow limitation - Airways... more |
| Speakers | Dr. Adrian J. Ivinson – Harvard Neurodiscovery Center, USA |
| Series |
Drug Discovery and Development in the Neurosciences |
| Relevant extract | Increasing numbers of neurological disorders correlates with the growing numbers of elderly - Paucity of drugs that treat these neurological disorders - Reasons for this failure - Need to reassess ... more |
| Speakers | Dr. Henrik Klitgaard – UCB, Belgium |
| Series |
Drug Discovery and Development in the Neurosciences |
| Relevant extract | Levetiracetam - Antiepileptic Drug Discovery - Levetiracetam in electroshock and PTZ seizures - Protection against seizures in rat model - Levetiracetam activity in GAERS model - Impact on cognitiv... more |
| Speakers | Dr. Roger Porter – Epilepsy Therapy Project, USA |
| Series |
Drug Discovery and Development in the Neurosciences Epilepsy and Seizures |
| Relevant extract | Seizures and epilepsy - Drugs for the symptomatic treatment of seizures - Finding new Anti-Seizure Drugs is a combination of serendipity, screening and rational approaches - Drug Development - Prec... more |
| Speakers | Dr. Todd Sherer – Michael J. Fox Foundation, USA |
| Series |
Drug Discovery and Development in the Neurosciences |
| Relevant extract | The need for disease-modifying therapies for Parkinson's disease - Promising targets and pathways - Genetics - Neurorestoration - Implicated biochemical pathways - Challenges for clinical translati... more |
| Speakers | Dr. Atsushi Kamiya – Johns Hopkins University School of Medicine, USA |
| Series |
Drug Discovery and Development in the Neurosciences |
| Relevant extract | Discovery of DISC1 - Potential Therapeutics strategies based on the structure and motif of DISC1 protein - DISC1-associated pathways as drug targets - Molecular complexities of DISC1 more |
| Speakers | Dr. Mikhail Pletnikov – Johns Hopkins University School of Medicine, USA |
| Series |
Drug Discovery and Development in the Neurosciences |
| Relevant extract | Animal models for schizophrenia - Animal models of psychiatric disorders - Non-genetic animals models - genetic animal models - DISC1 anima models - Weaknesses of the current animal models for schi... more |